$OPRX News
Last published 3h ago
- 3h agoOPRXOptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 GuidanceGlobeNewswireQ3 revenue totals $21.6 millionQ3 net income and adjusted EBITDA of $1.2 million and $6.3 million2026 revenue guidance updated to $87-$93 million; adjusted...
- 2w agoOPRXOptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 2w agoOPRXOptimizeRx and PulsePoint Partner to Connect HCP Media Across the FunnelGlobeNewswireWALTHAM, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a healthcare technology company helping life sciences companies reach and engage healthcare professionals
- 2mo agoOPRXOptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth ConferenceGlobeNewswireWALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 2mo agoOPRXOptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company AdvisorGlobeNewswireWALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 3mo agoOPRXOptimizeRx Corporation Second Quarter 2026 Conference Call - OPTIMIZERX CORPEarnings Call TranscriptsGood afternoon, everyone, and thank you for joining OptimizeRx's second quarter fiscal 2026 earnings conference call. With us today is Chief Executive Officer Stephen Silvestro. He is joined by Chief Financial Strategy O
- 3mo agoOPRXOptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of GrowthGlobeNewswireThe Company Names Andy D’Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027 Planned Transition Reflects Strong Succession Planning and Deep Leadership
- 3mo agoOPRXOptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 GuidanceGlobeNewswire– Q2 revenue totals $20.5 million– Q2 net loss and adjusted EBITDA of $(0.7) million and $4.9 million, respectively– Reaffirms fiscal year 2026 revenue guidance of $95 - $100 million and adjusted EBITDA guidance of
- 3mo agoOPRXOptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 3mo agoOPRXOptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing OfficerGlobeNewswireWALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 4mo agoOPRXOptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing IntentGlobeNewswireWALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 4mo agoOPRXOptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning PlatformsGlobeNewswireWALTHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage
- 5mo agoOPRXOptimizeRx to Participate in Upcoming Investor ConferencesGlobeNewswireWALTHAM, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals
- 5mo agoOPRXDeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR NetworkGlobeNewswireWALTHAM, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and
- 6mo agoOPRXOptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 GuidanceGlobeNewswire– Q1 revenue totals $19.8 million– Q1 net loss and adjusted EBITDA came in at $(0.5) million and $3.3 million, respectively– 2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance unchanged at
- 6mo agoOPRXOptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at ScaleGlobeNewswireWALTHAM, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 6mo agoOPRXOptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) ReportGlobeNewswireWALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 6mo agoOPRXOptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals
- 6mo agoMYOOPRXMyomo Appoints William J Febbo to its Board of DirectorsBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 7mo agoOPRXOptimizeRx Appoints Mary Varghese Presti to Board of DirectorsGlobeNewswireWALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals
- 8mo agoOPRXUPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire- Q4 revenue of $32.2 million- Q4 gross profit increased 9% year-over-year to $24.1 million- Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively- Updating 2026 revenue
- 8mo agoOPRXOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire- Q4 revenue of $32.2 million- Q4 gross profit increased 9% year-over-year to $24.1 million- Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively- Updating 2026 revenue
- 9mo agoOPRXOptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 10mo agoOPRXOptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare MarketingGlobeNewswireWALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage healthcare
- 10mo agoOPRXOptimizeRx Continues Expansion of the Company's Point-Of-Care NetworkGlobeNewswireWALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 GuidanceGlobeNewswire- Q3 revenue of $26.1 million, increased 22% year-over-year- Q3 gross profit increased 30% year-over-year to $17.5 million- Increases full year 2025 guidance to a revenue range between $105 million and $109 million
- 1y agoOPRXOptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth ConferenceGlobeNewswireWALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoLAMROPRXOptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare AdvertisingGlobeNewswireStrategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025
- 1y agoOPRXOptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic GrowthGlobeNewswireWALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Corporation (OPRX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoOPRXOptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewswireQ2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased full year 2025
- 1y agoOPRXOptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Corporation Appoints CEO Steve Silvestro to Board of DirectorsGlobeNewswireWALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXSimulmedia and OptimizeRx Announce Partnership from the Cannes LionsBusiness WireStrategic Collaboration Brings Precision Micro-Neighborhood® Targeting Healthcare Consumer Audiences to Linear and Connected TV Simulmedia, a national leader in data-driven TV and streaming advertising, today
- 1y agoOPRXOptimizeRx to Participate in Upcoming Investor ConferencesGlobeNewswireWALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewswireQ1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and
- 1y agoOPRXOptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) ReportGlobeNewswireWALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Corporation Announces Plan for Additional Board of Directors RefreshmentGlobeNewswireWALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireQ4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023
- 1y agoOPRXOptimizeRx Corporation Confirms Receipt of Notice of Director NominationsGlobeNewswireWALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive OfficerGlobeNewswireWALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ETGlobeNewswireWALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEOGlobeNewswireWALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx to Participate in Upcoming Investor ConferencesGlobeNewswireWALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 1y agoOPRXOptimizeRx Corporation (OPRX) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoOPRXOptimizeRx Reports Third Quarter 2024 Financial ResultsGlobeNewswire- Q3 revenue of $21.3 million, increasing 30% year-over-year - Q3 gross profit increased 37% year-over-year to $13.4 million with a gross margin of 63% - Won 5 DAAP deals during Q3 WALTHAM, Mass., Nov.
- 2y agoOPRXOptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ETGlobeNewswireWALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
- 2y agoOPRXOptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total ValueGlobeNewswireWALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare